Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as a 350 mg I/mL solution for injection for intraarterial, intraarticular, and intrathecal use. It enhances radiographic contrast in diagnostic imaging procedures such as angiography, arthrography, myelography, and CT scans.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, imaging centres, and clinics worldwide.

Iomeron, an iodinated contrast agent, is used to improve visualization in imaging studies that involve vascular, joint, spinal, or cross‑sectional anatomy.

Angiography: provides enhanced vessel delineation for diagnostic and interventional procedures. Arthrography: improves joint space contrast to assess cartilage and ligaments. Myelography: increases contrast of the subarachnoid space for spinal imaging. CT imaging: augments tissue differentiation in computed tomography scans.

Iomeron may cause a range of adverse reactions, from mild to severe, depending on patient sensitivity and administered volume.

Common Side Effects: - Warm sensation or flushing at the injection site - Transient metallic taste in the mouth - Nausea or mild vomiting - Headache or mild dizziness

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction - Acute renal impairment, especially in patients with pre‑existing kidney disease - Hypotension or cardiovascular collapse - Pulmonary edema or severe respiratory distress

Prior to using Iomeron, clinicians should evaluate patient risk factors and follow safe handling practices.

Assess renal function before administration: evaluate eGFR and consider hydration. Screen for iodine allergy: avoid in patients with known hypersensitivity. Use the lowest effective dose: tailor volume to the specific imaging requirement. Monitor vital signs during injection: watch for hypotension or acute reactions. Store at ambient temperature: keep below 25 °C, protect from light and moisture, retain in the original container.

Iomeron can interact with other agents that affect renal function, thyroid status, or cardiovascular stability.

Major Interactions (Avoid): - Concurrent use of other iodinated contrast agents within 24 h: risk of cumulative iodine load. - Co‑administration with nephrotoxic drugs (e.g., aminoglycosides, NSAIDs): increased risk of renal injury. - Use with beta‑blockers: may mask contrast‑induced hypertension.

Moderate Interactions (Monitor Closely): - Thyroid hormone therapy: iodine load may alter thyroid function tests. - Diuretics: may affect renal clearance of the contrast medium. - Metformin in patients with impaired renal function: consider temporary discontinuation to prevent lactic acidosis.